Credit Suisse Starts Fulgent Genetics (FLGT) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazilās Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Britain will not join Canada-led defence bank initiativeĀ
- CAE agrees to sell Flightscape unit to SITA for $500 million
Piper Jaffray Starts Fulgent Genetics (FLGT) at Overweight
October 24, 2016 7:33 AM EDTPiper Jaffray initiated coverage on Fulgent Genetics (NASDAQ: FLGT) with an Overweight rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Fulgent Genetics click here. For more ratings news on Fulgent Genetics click here.
Shares of Fulgent Genetics closed at $8.88 yesterday.
... MoreBTIG Starts Fulgent Genetics (FLGT) at Buy
October 24, 2016 7:32 AM EDTBTIG initiated coverage on Fulgent Genetics (NASDAQ: FLGT) with a Buy rating and a price target of $15.
Analyst Karen Koski said, "While the genetic testing market is not without challenges and competition is formidable, we believe Fulgents proprietary technology platform drives multiple sustainable... More



